ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
125.999 IP-LS
Project title
Developing First-In-Class INPP5A Inhibitors as the First Effective Therapy for All GNAQ/11 Mutated Metastatic Uveal Melanoma Patients
Project status In Process
 
Start date 01.07.2025
End date 31.12.2026
 
Granted total costs 401'621.15  CHF
Section 60 Life Sciences
Project category Project
Research type Applied research and development
NABS classification Industrial production and technology
 
Research disciplines
100 % B007 Medicine (human and vertebrates)
Last modification of the project